This article {extract} was published in Communicable Diseases Intelligence Vol 31 No 1 March 2007 and may be downloaded as a full version PDF from the Table of contents page.
Results, continued
Table 4. Notifications and notification rate for communicable diseases, Australia, 2001 to 2005, (per 100,000 population)
Disease |
Notifications | Rate per 100,000 population | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
2001 | 2002 | 2003 | 2004 | 2005 | 2001 | 2002 | 2003 | 2004 | 2005 | |
Bloodborne diseases |
||||||||||
Hepatitis B (incident) | 422 |
383 |
345 |
282 |
245 |
2.2 |
2.0 |
1.7 |
1.4 |
1.2 |
Hepatitis B (unspecified)* | 8,025 |
6,353 |
5,824 |
5,829 |
6,396 |
41.2 |
32.3 |
29.3 |
29.0 |
31.5 |
Hepatitis C (incident) | 694 |
438 |
518 |
453 |
357 |
3.6 |
2.2 |
2.6 |
2.3 |
1.8 |
Hepatitis C (unspecified)*,† | 19,370 |
14,462 |
13,716 |
12,993 |
12,250 |
99.4 |
73.6 |
69.0 |
64.6 |
60.3 |
Hepatitis D | 20 |
20 |
27 |
28 |
30 |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
Gastrointestinal diseases |
||||||||||
Botulism | 2 |
0 |
1 |
1 |
3 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Campylobacteriosis‡ | 16,134 |
14,740 |
15,357 |
15,579 |
16,468 |
125.3 |
113.3 |
116.4 |
116.4 |
121.5 |
Cryptosporidiosis | 1,629 |
3,266 |
1,223 |
1,684 |
3,209 |
8.4 |
16.6 |
6.2 |
8.4 |
15.8 |
Haemolytic uraemic syndrome | 3 |
12 |
15 |
16 |
20 |
0.0 |
0.1 |
0.1 |
0.1 |
0.1 |
Hepatitis A | 539 |
388 |
431 |
319 |
325 |
2.8 |
2.0 |
2.2 |
1.6 |
1.6 |
Hepatitis E | 14 |
12 |
12 |
28 |
31 |
0.1 |
0.1 |
0.1 |
0.1 |
0.2 |
Listeriosis | 64 |
62 |
69 |
67 |
54 |
0.3 |
0.3 |
0.3 |
0.3 |
0.3 |
Salmonellosis (NEC) | 7,050 |
7,699 |
7,008 |
7,834 |
8,441 |
36.2 |
39.2 |
35.2 |
39.0 |
41.5 |
Shigellosis | 567 |
504 |
442 |
520 |
732 |
2.9 |
2.6 |
2.2 |
2.6 |
3.6 |
SLTEC, VTEC§ | 46 |
58 |
52 |
49 |
87 |
0.2 |
0.3 |
0.3 |
0.2 |
0.4 |
Typhoid | 77 |
68 |
51 |
76 |
52 |
0.4 |
0.3 |
0.3 |
0.4 |
0.3 |
Quarantinable diseases |
||||||||||
Cholera | 4 |
5 |
1 |
5 |
3 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Plague | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Rabies | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Severe acute respiratory syndrome | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Smallpox | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Tularaemia | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Viral haemorrhagic fever | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Yellow fever | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Sexually transmitted infections |
||||||||||
Chlamydial infections (NEC)|| | 20,330 |
24,043 |
30,439 |
36,227 |
41,311 |
104.3 |
122.4 |
153.1 |
180.1 |
203.2 |
Donovanosis | 32 |
17 |
16 |
10 |
13 |
0.2 |
0.1 |
0.1 |
0.0 |
0.1 |
Gonococcal infection | 6,291 |
6,279 |
6,792 |
7,187 |
8,015 |
32.3 |
32.0 |
34.2 |
35.7 |
39.4 |
Syphilis (all)¶ | 1,851 |
1,958 |
2,007 |
2,332 |
2,203 |
9.5 |
10.0 |
10.1 |
11.6 |
10.8 |
Syphilis < 2 years duration | 0 |
0 |
0 |
615 |
621 |
0.0 |
0.0 |
0.0 |
3.1 |
3.1 |
Syphilis > 2 years or unknown duration | 1,851 |
1,958 |
2,007 |
1,717 |
1,582 |
9.5 |
10.0 |
10.1 |
8.5 |
7.8 |
Syphilis – congenital | 21 |
18 |
13 |
12 |
15 |
0.1 |
0.1 |
0.1 |
0.1 |
0.1 |
Vaccine preventable diseases |
||||||||||
Diphtheria | 1 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Haemophilus influenzae type b | 20 |
30 |
19 |
15 |
17 |
0.1 |
0.2 |
0.1 |
0.1 |
0.1 |
Influenza (laboratory confirmed)** | 1,294 |
3,652 |
3,483 |
2,133 |
4,567 |
6.6 |
18.6 |
17.5 |
10.6 |
22.5 |
Measles | 141 |
32 |
93 |
45 |
10 |
0.7 |
0.2 |
0.5 |
0.2 |
0.0 |
Mumps | 116 |
67 |
77 |
102 |
241 |
0.6 |
0.3 |
0.4 |
0.5 |
1.2 |
Pertussis | 9,506 |
5,407 |
5,096 |
8,752 |
11,200 |
48.8 |
27.5 |
25.6 |
43.5 |
55.1 |
Poliomyelitis | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Pneumococcal disease (invasive) | 1,761 |
2,432 |
2,238 |
2,296 |
1,684 |
9.0 |
12.4 |
11.3 |
11.4 |
8.3 |
Rubella | 264 |
254 |
54 |
31 |
31 |
1.4 |
1.3 |
0.3 |
0.2 |
0.2 |
Rubella – congenital | 0 |
1 |
3 |
1 |
1 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Tetanus | 3 |
4 |
4 |
5 |
2 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Vectorborne diseases |
||||||||||
Barmah Forest virus infection | 1,143 |
867 |
1,369 |
1,106 |
1,319 |
5.9 |
4.4 |
6.9 |
5.5 |
6.5 |
Dengue | 131 |
165 |
860 |
351 |
218 |
0.7 |
0.8 |
4.3 |
1.7 |
1.1 |
Flavivirus infection (NEC)†† | 88 |
72 |
60 |
61 |
29 |
0.5 |
0.4 |
0.3 |
0.3 |
0.1 |
Japanese encephalitis virus | 0 |
0 |
1 |
1 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Kunjin virus‡‡ | 5 |
0 |
18 |
12 |
1 |
0.0 |
0.0 |
0.1 |
0.1 |
0.0 |
Malaria | 719 |
462 |
595 |
558 |
822 |
3.7 |
2.4 |
3.0 |
2.8 |
4.0 |
Murray Valley encephalitis virus | 6 |
2 |
0 |
1 |
2 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Ross River virus infection | 3,226 |
1,451 |
3,850 |
4,210 |
2,544 |
16.6 |
7.4 |
19.4 |
20.9 |
12.5 |
Zoonoses |
||||||||||
Anthrax | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Australian bat lyssavirus | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Brucellosis | 21 |
40 |
20 |
39 |
41 |
0.1 |
0.2 |
0.1 |
0.2 |
0.2 |
Leptospirosis | 250 |
159 |
127 |
177 |
130 |
1.3 |
0.8 |
0.6 |
0.9 |
0.6 |
Ornithosis§§ | 137 |
199 |
199 |
237 |
161 |
0.7 |
1.0 |
1.0 |
1.2 |
0.792 |
Lyssavirusunspecified | 0 |
0 |
0 |
0 |
0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Q fever | 693 |
762 |
562 |
463 |
355 |
3.6 |
3.9 |
2.8 |
2.3 |
1.7 |
Other bacterial infections |
||||||||||
Legionellosis | 310 |
313 |
333 |
312 |
335 |
1.6 |
1.6 |
1.7 |
1.6 |
1.6 |
Leprosy | 10 |
6 |
5 |
7 |
10 |
0.1 |
0.0 |
0.0 |
0.0 |
0.0 |
Meningococcal infection|||| | 686 |
681 |
558 |
405 |
394 |
3.5 |
3.5 |
2.8 |
2.0 |
1.9 |
Tuberculosis | 932 |
1,041 |
959 |
1,061 |
1,087 |
4.8 |
5.3 |
4.8 |
5.3 |
5.3 |
Total | 104,648 |
98,884 |
104,942 |
113,912 |
125,461 |
* Unspecified hepatitis includes cases in whom the duration of infection could not be determined.
† In Queensland, includes incident hepatitis cases.
‡ Notified as 'foodborne disease' or 'gastroenteritis in an institution' in New South Wales.
§ Infection with Shiga-like toxin-/verotoxin-producing Escherchia coli (SLTEC/VTEC).
|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral, throat and eye samples, except for South Australia which reports only genital tract specimens; the Northern Territory which excludes ocular specimens; and Western Australia which excludes ocular and perinatal infections.
¶ Does not include congenital syphilis.
** Laboratory-confirmed influenza is not a notifiable disease in South Australia but reports are forwarded to NNDSS.
†† Flavivirus (NEC) replaced Arbovirus (NEC) from 1 January 2004.
‡‡ In the Australian Capital Territory, Murray Valley encephalitis virus and Kunjin virus are combined under Murray Valley encephalitis virus.
§§ In the Australian Capital Territory, ornithosis is reported as chlamydia not elsewhere classified.
|||| Only invasive meningococcal disease is nationally notifiable. However, New South Wales, the Australian Capital Territory and South Australia also report conjunctival cases.
NN Not notifiable.
NEC Not elsewhere classified.
In 2005, the total number of notifications was the highest recorded in NNDSS since the system began in 1991. There was an increase of 10% compared to the total number of notifications in 2004 (Figure 2).
Figure 2. Trends in notifications received by the National Notifiable Diseases Surveillance System, Australia, 1991 to 2005
In 2005, the most frequently notified diseases were sexually transmissible infections (51,557 notifications, 41% of total notifications), gastrointestinal diseases (29,422 notifications, 23%) and bloodborne diseases (19,278 notifications, 15%).
There were 17,753 notifications of vaccine preventable diseases; 4,935 notifications of vectorborne diseases; 1,826 notification of other bacterial infections and 687 notifications of zoonotic diseases (Figure 3).
Figure 3. Notifications to the National Notifiable Diseases Surveillance System, Australia, 2005, by disease category
The major changes in communicable disease notifications in 2005 are shown in Figure 4 as the ratio of notifications in 2005 to the mean number of notifications for the previous 5 years. The number of notifications of chlamydial, gonococcal, shigellosis, mumps, pertussis, SLTEC/VTEC and hepatitis E infections surpassed the expected range (5-year mean plus 2 standard deviations). Notifications of hepatitis B (incident), Q fever, flavivirus and listeriosis infections were below the expected range (5-year mean minus 2 standard deviations). Notifications for the remaining diseases were within the historical range.
Figure 4. Comparison of total notifications of selected diseases reported to the National Notifiable Diseases Surveillance System in 2005, with the previous 5-year mean
* Number of notifications surpassed the expected range (i.e. 5-year mean +2 standard deviations).
† Number of notifications was less than the expected range (i.e. 5-year mean –2 standard deviations).
In the financial year 2004–05, there were 87,520 hospital separations in Australian hospitals with a primary diagnosis of infectious diseases (International Classification of Diseases, version 10, Australian Modification (ICD10–AM) codes A01–B99, Australian Institute of Health and Welfare). This represents 1.2% of all hospital separations in that period. A further 65,494 separations were recorded with a principal diagnosis of influenza or pneumonia (ICD10–AM J10–J18).1
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 31 No 1, March 2007
NNDSS Annual report 2005
Communicable Diseases Intelligence